Back
Context Therapeutics Stock Price Chart
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.
Buy
66
CNTX
Context Therapeutics
Last Price:
2.26
Seasonality Move:
-23.73%
7 Day Trial
ALL ACCESS PASS
$
7
10 minutes on Tuesday - $1,270 by Friday?
Click here to discover how this "odd" trade could double your money each week.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CNTX is experiencing selling pressure, which indicates risk of future bearish movement.
Context Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.12 | Buy |
| 20-day SMA: | 2.28 | Sell |
| 50-day SMA: | 2.3 | Sell |
| 200-day SMA: | 1.63 | Buy |
| 8-day EMA: | 2.16 | Buy |
| 20-day EMA: | 2.23 | Buy |
| 50-day EMA: | 2.23 | Buy |
| 200-day EMA: | 1.79 | Buy |
Context Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 49.85 | Sell |
| Chaikin Money Flow: | -385854 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.15 - 2.51) | Sell |
| Bollinger Bands (100): | (1.83 - 2.37) | Buy |
Context Therapeutics Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Context Therapeutics Stock
Is Context Therapeutics Stock a Buy?
- Context Therapeutics share price is 2.25 while CNTX 8-day simple moving average is 2.12, which is a Buy signal.
- The stock price of CNTX is 2.25 while Context Therapeutics 20-day SMA is 2.28, which makes it a Sell.
- Context Therapeutics 50-day simple moving average is 2.30 while CNTX share price is 2.25, making it a Sell technically.
- CNTX stock price is 2.25 and Context Therapeutics 200-day simple moving average is 1.63, creating a Buy signal.
CNTX Technical Analysis vs Fundamental Analysis
Buy
66
Context Therapeutics (CNTX)
is a Buy
Is Context Therapeutics a Buy or a Sell?
-
Context Therapeutics stock is rated a Buy
The current Context Therapeutics [CNTX] share price is $2.25. The Score for CNTX is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
Context Therapeutics Stock Info
Market Cap:
168.75M
Price in USD:
2.25
Share Volume:
452.96K
Context Therapeutics 52-Week Range
52-Week High:
2.75
52-Week Low:
0.77
Buy
66
Context Therapeutics (CNTX)
is a Buy
Context Therapeutics Share Price Forecast
-
What is the Context Therapeutics stock price today?
The Context Therapeutics stock price is 2.25 USD today. -
Will CNTX stock go up or go down?
Context Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Context Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Context Therapeutics is not overvalued.
Is Context Therapeutics Stock a Buy?
- Context Therapeutics share price is 2.25 while CNTX 8-day exponential moving average is 2.16, which is a Buy signal.
- The stock price of CNTX is 2.25 while Context Therapeutics 20-day EMA is 2.23, which makes it a Buy.
- Context Therapeutics 50-day exponential moving average is 2.23 while CNTX share price is 2.25, making it a Buy technically.
- CNTX stock price is 2.25 and Context Therapeutics 200-day simple moving average is 1.79, creating a Buy signal.
Fundamental Analysis of Context Therapeutics
Is Context Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.02 per share, an increase this year of $1.14 per share, and a decrease next year of $0.02 per share.
Technical Analysis of Context Therapeutics
Should I short Context Therapeutics stock?
- CNTX Moving Average Covergence Divergence (MACD) indicator is -0.06, suggesting Context Therapeutics is a Sell
- Context Therapeutics Relative Strength Index (RSI) is 49.85, which suggest Context Therapeutics is oversold
- The Bollinger Bands (25) for Context Therapeutics is (2.15 - 2.51), which suggest Context Therapeutics is a Buy
- The Bollinger Bands (100) for Context Therapeutics is (1.83 - 2.37), which suggest Context Therapeutics is a Buy
* Context Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.